The global antifungal drugs market is estimated to have reached $14bn in 2018 and is expected to grow at a CAGR of 3.8% during the forecast period. In 2018, the global antifungal drugs market was dominated by Azoles.

How this report will benefit youRead on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 203-page report you will receive 85 tables and 101 figures– all unavailable elsewhere.

• Key Questions Answered by this Report:• How is the Antifungal Drugs market evolving?• How will each Antifungal Drugs submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2029?• How will the market shares for each Antifungal Drugs submarket develop from 2019 to 2029?• Will leading national Antifungal Drugs markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?• How will the market shares of the national markets change by 2029 and which geographical region will lead the market in 2029?• Who are the leading players?• How will the industry evolve during the period between 2019 and 2029?